Literature DB >> 31296452

Japanese Case of Enzalutamide-Resistant Prostate Cancer Harboring a SPOP Mutation With Scattered Allelic Imbalance: Response to Platinum-Based Therapy.

Keitaro Watanabe1, Takeo Kosaka2, Eriko Aimono3, Hiroshi Hongo1, Shuji Mikami4, Hiroshi Nishihara3, Mototsugu Oya1.   

Abstract

Entities:  

Keywords:  Enzalutamide-resistant; Neuroendocrine differentiation; Platinum-based therapy; Prostate cancer; SPOP mutation

Mesh：

Substances：

Year:  2019        PMID： 31296452     DOI： 10.1016/j.clgc.2019.06.005

Source DB:  PubMed          Journal:  Clin Genitourin Cancer        ISSN： 1558-7673            Impact factor:   2.872


× No keyword cloud information.
  4 in total

1.  Hybridisation chain reaction-based visualisation and screening for lncRNA profiles in clear-cell renal-cell carcinoma.

Authors:  Ryohei Kufukihara; Nobuyuki Tanaka; Kimiharu Takamatsu; Naoya Niwa; Keishiro Fukumoto; Yota Yasumizu; Toshikazu Takeda; Kazuhiro Matsumoto; Shinya Morita; Takeo Kosaka; Eriko Aimono; Hiroshi Nishihara; Ryuichi Mizuno; Mototsugu Oya
Journal:  Br J Cancer       Date:  2022-06-28       Impact factor: 9.075

2.  A first Japanese case of neuroendocrine prostate cancer accompanied by lung and brain metastasis with somatic and germline BRCA2 mutation.

Authors:  Takeo Kosaka; Hiroshi Hongo; Eriko Aimono; Kazuhiro Matsumoto; Tetsu Hayashida; Shuji Mikami; Hiroshi Nishihara; Mototsugu Oya
Journal:  Pathol Int       Date:  2019-10-20       Impact factor: 2.534

3.  Pulmonary metastasis secondary to abiraterone-resistant prostate cancer with homozygous deletions of BRCA2: First Japanese case.

Authors:  Mizuki Izawa; Takeo Kosaka; Kohei Nakamura; Junna Oba; Tomoyuki Hishida; Hiroshi Hongo; Shuji Mikami; Hiroshi Nishihara; Mototsugu Oya
Journal:  IJU Case Rep       Date:  2020-10-15

4.  Prominent response to platinum-based chemotherapy in a patient with BRCA2 mutant-neuroendocrine prostate cancer and MDM2 amplification.

Authors:  Tatsuaki Daimon; Takeo Kosaka; Hiroshi Hongo; Eriko Aimono; Kohei Nakamura; Shuji Mikami; Hiroshi Nishihara; Mototsugu Oya
Journal:  IJU Case Rep       Date:  2021-05-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.